representative work

Pond Technologies Holdings Completes Acquisition of Regenurex Health Corporation


On January 30, 2019, Pond Technologies Holdings Inc. completed its acquisition of Regenurex Health Corporation. The acquisition was completed by way of a three cornered amalgamation of Regenurex and a wholly owned subsidiary of Pond, Pond Naturals Inc., with the resulting entity continuing under the name Pond Naturals.

Pursuant to the amalgamation, former holders of the Class A preferred shares of Regenurex received an aggregate of 3,539,198 non-voting senior preferred shares of Pond Naturals and 18,219,200 non-voting junior preferred shares of Pond Naturals.

Cassels acted for Pond Technologies with a deal team that included Cam Mingay, Evan Low and Daniel Zuniga (Securities and M&A).